CD8A and cancer: NLRP3 in the primary lesion of cancer cells drives the production of pro-IL-1β, DC maturation, and the secretion of IL-1β to support the evolution of tumor-specific CD8+ T cells (41). Moreover, Dupaul-Chicoine et al.